{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:45:51Z","timestamp":1747183551076,"version":"3.40.5"},"reference-count":72,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:00:00Z","timestamp":1717891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["18\/06569\u20109"],"award-info":[{"award-number":["18\/06569\u20109"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>A population\u2010based pharmacokinetic (PK) modeling approach (PopPK) was used to investigate the impact of Roux\u2010en\u2010Y gastric bypass (RYGB) on the PK of (<jats:italic>R<\/jats:italic>)\u2010 and (<jats:italic>S<\/jats:italic>)\u2010carvedilol. We aimed to optimize carvedilol dosing for these patients utilizing a pharmacokinetic\/pharmacodynamic (PK\/PD) link model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PopPK models were developed utilizing data from 52 subjects, including nonobese, obese, and post\u2010 RYGB patients who received <jats:italic>rac<\/jats:italic>\u2010 carvedilol orally. Covariate analysis included anthropometric and laboratory data, history of RYGB surgery, CYP2D6 and CYP3A4 in vivo activity, and relative intestinal abundance of major drug\u2010 metabolizing enzymes and transporters. A direct effect inhibitory E<jats:sub>max<\/jats:sub> pharmacodynamic model was linked to the PK model of (<jats:italic>S<\/jats:italic>)\u2010 carvedilol to simulate the changes in exercise\u2010 induced heart rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 2\u2010compartmental model with linear elimination and parallel first\u2010order absorptions best described (<jats:italic>S<\/jats:italic>)\u2010carvedilol PK. RYGB led to a twofold reduction in relative oral bioavailability compared to nonoperated subjects, along with delayed absorption of both enantiomers. The intestinal <jats:italic>ABCC2<\/jats:italic> mRNA expression increases the time to reach the maximum plasma concentration. The reduced exposure (AUC) of (S)\u2010carvedilol post\u2010RYGB corresponded to a 33% decrease in the predicted area under the effect curve (AUEC) for the 24\u2010hour \u03b2\u2010blocker response. Simulation results suggested that a 50\u2010mg daily dose in post\u2010RYGB patients achieved comparable AUC and AUEC to 25\u2010mg dose in nonoperated subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Integrated PK\/PD modeling indicated that standard dosage regimens for nonoperated subjects do not provide equivalent \u03b2\u2010blocking activity in RYGB patients. This study highlights the importance of personalized dosing strategies to attain desired therapeutic outcomes in this patient cohort.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.16129","type":"journal-article","created":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T23:07:37Z","timestamp":1717974457000},"page":"2223-2235","source":"Crossref","is-referenced-by-count":1,"title":["Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population\u2010based analysis"],"prefix":"10.1111","volume":"90","author":[{"given":"Priscila Akemi","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando FL USA"},{"name":"School of Pharmaceutical Sciences of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valvanera","family":"Vozmediano","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Cristofoletti","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmai","family":"Jiang","sequence":"additional","affiliation":[{"name":"Cancer Genetics Research Complex, College of Pharmacy University of Florida  Gainesville FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schmittgen","sequence":"additional","affiliation":[{"name":"Cancer Genetics Research Complex, College of Pharmacy University of Florida  Gainesville FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Masetto","family":"de Gaitani","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Kemp","sequence":"additional","affiliation":[{"name":"School of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajith Kumar","family":"Sankarankutty","sequence":"additional","affiliation":[{"name":"School of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Sebasti\u00e3o","family":"dos Santos","sequence":"additional","affiliation":[{"name":"School of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Salgado Junior","sequence":"additional","affiliation":[{"name":"School of Medicine of Ribeir\u00e3o Preto University of S\u00e3o Paulo (USP)  Ribeir\u00e3o Preto SP Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-058X","authenticated-orcid":false,"given":"Natalia Valadares","family":"de Moraes","sequence":"additional","affiliation":[{"name":"Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida  Orlando FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,6,9]]},"reference":[{"volume-title":"Adult obesity facts","author":"Centers for Disease Control and Prevention","key":"e_1_2_10_2_1"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2377"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.2229"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.953804"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21\u20102498"},{"volume-title":"Estimate of bariatric surgery numbers, 2011\u20132020","author":"American society for metabolic and bariatric surgery","key":"e_1_2_10_7_1"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q414"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0563"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(20)30302\u20102"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2021.01.016"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2022.12.018"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695\u2010021\u201005308\u2010x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.01.009"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249\u2010015\u20100365\u20102"},{"issue":"12","key":"e_1_2_10_16_1","first-page":"784","article-title":"The effects of surfactants on the solubility and dissolution profiles of a poorly water\u2010soluble basic drug, carvedilol","volume":"70","author":"Incecayir T","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088\u2010199426050\u201000002"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24505"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01409476"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.31.1297"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.2146"},{"issue":"8","key":"e_1_2_10_22_1","first-page":"970","article-title":"In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)\u2010 and S(\u2212)\u2010carvedilol","volume":"25","author":"Oldham HG","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2016.08.007"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344\u2010198710111\u201000015"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751\u20107176.2010.00386.x"},{"volume-title":"COREG (carvedilol)","author":"GlaxoSmithKline (GSK)","key":"e_1_2_10_26_1"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19\u20103781"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031505"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2221"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875\u20109114.2012.01108.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.129306"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123338"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111596"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs\u20102018\u20100115"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.1985.tb05112.x"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12109"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.1991.tb03939.x"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.082826"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.032094"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2005.05.011"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1125"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010011\u20109290\u20109"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.14"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2012.4"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.07.016"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.4.667"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/107424849900400402"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40495\u2010017\u20100096\u2010z"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.34"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050628"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.07.014"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12829"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16181"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16182"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600790704"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552\u20104604.1986.tb02953.x"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495\u2010198800366\u201000015"},{"issue":"6","key":"e_1_2_10_61_1","first-page":"709","article-title":"Pharmacokinetics of carvedilol in older and younger patients","volume":"4","author":"Morgan T","year":"1990","journal-title":"J Hum Hypertens"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695\u2010021\u201005452\u20104"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13054"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.19903230805"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.05.033"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2558"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.014407"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15349"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.1986.tb02837.x"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.615"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010019\u201057002\u20109"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.10.004"},{"issue":"5","key":"e_1_2_10_73_1","first-page":"1265","article-title":"Assessment of sex differences in pharmacokinetics of carvedilol in human","volume":"27","author":"Abbas M","year":"2014","journal-title":"Pak J Pharm Sci"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.16129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T08:09:14Z","timestamp":1724918954000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.16129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/bcp.16129"],"URL":"https:\/\/doi.org\/10.1111\/bcp.16129","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2024,6,9]]}}}